psoriasis
PSORIASIS

Psoriasis is a systemic chronic skin disorder characterized by excessive keratinocytes proliferation that results into thickened scaly plaques, itching and inflammatory changes in the epidermis and dermis. It is transmitted genetically but can be provoked by environmental factors.
It is found in approximately 2% of the population that primarily affects the skin and joints.
It is associated with other inflammatory disorders and autoimmune diseases (eg psoriatic arthritis, inflammatory bowel disease, coronary artery disease).
Generally, it begins as red scaling papules that coalesce to form round-to-oval plaques. The rashes are often pruritic and may be painful.

Drug Information

Indication: Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy....

Indication: Signs & symptoms & inhibiting the progression of structural damage in moderately to severely active rh...

Indication: Prophylaxis of transplant rejection in adult kidney or liver allograft receipients. Kidney or liver allograft ...

Indication: Adult & childn ≥3 mth: Atopic, infantile & discoid eczemas, prurigo nodularis, psoriasis (excluding...

Indication: Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses eg, psoriasis (excluding...

Indication: Short-term treatment & intermittent long-term therapy of mild to moderate of atopic dermatitis in non-immu...

Indication: Strengthen skin's protective function; increases moisture & lipid content. Reduces feeling of tautness &am...

Indication: Primary immunosuppression in liver & kidney allograft recipients & liver & kidney allograft reject...

Dosage: Adult RA Initially 3 mg/kg IV infusion over 2-hr, followed by additional 3 mg/kg doses at 2 & 6 wk after t

Indication: Moderate to severe plaque psoriasis in adult patient who failed to respond, contraindicated, or are intolerant...

1  /  12
Editor's Recommendations
Most Read Articles
20 Sep 2019
Both adalimumab and phototherapy increase overall and skin-related quality of life (QoL) in psoriasis patients, although phototherapy appears to be better, a recent study has shown.
Roshini Claire Anthony, 24 Sep 2019

Once-daily oral omadacycline demonstrated noninferiority to twice-daily linezolid in treating acute bacterial skin and skin structure infections (ABSSSI), the phase III OASIS-2* study showed.